| Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy Y Wei, L Gao, L Wang, L Shi, E Wei, B Zhou, L Zhou, B Ge Drug Delivery 24 (1), 681-691, 2017 | 183 | 2017 |
| Anti-proliferative benefit of curcumol on human bladder cancer cells via inactivating EZH2 effector L Zhou, E Wei, B Zhou, G Bi, L Gao, T Zhang, J Huang, Y Wei, B Ge Biomedicine & Pharmacotherapy 104, 798-805, 2018 | 31 | 2018 |
| Integration of scRNA-Seq and TCGA RNA-Seq to analyze the heterogeneity of HPV+ and HPV-cervical cancer immune cells and establish molecular risk models E Wei, A Reisinger, J Li, LE French, B Clanner-Engelshofen, M Reinholz Frontiers in Oncology 12, 860900, 2022 | 20 | 2022 |
| Comparison of Different Anti-Demodex Strategies: A Systematic Review and Meta-Analysis J Li, E Wei, A Reisinger, LE French, BM Clanner-Engelshofen, ... Dermatology 239 (1), 12-31, 2023 | 13 | 2023 |
| MiR-26a inhibits cell proliferation and induces apoptosis in human bladder cancer through regulating EZH2 bioactivity B Zhou, E Wei, H Shi, J Huang, L Gao, T Zhang, Y Wei, B Ge International journal of clinical and experimental pathology 10 (11), 11234, 2017 | 9 | 2017 |
| The effectiveness of an extra-curricular lecture for STI prevention and sexual education M Reinholz, T Nellessen, E Wei, S Zippel, C Fuchs, T Kaemmerer, ... Epidemiology & Infection 151, e35, 2023 | 7 | 2023 |
| “From molecular to clinic”: The pivotal role of CDC42 in pathophysiology of human papilloma virus related cancers and a correlated sensitivity of afatinib E Wei, J Li, P Anand, LE French, A Wattad, B Clanner-Engelshofen, ... Frontiers in Immunology 14, 1118458, 2023 | 2 | 2023 |
| The Role of Laundry Detergents in the Elements of Skin Pathogen E Wei, M Reinholz, LE French, BM Clanner-Engelshofen | 1 | 2021 |
| Pharmacological targeting of P300/CBP reveals EWS:: FLI1-mediated senescence evasion in Ewing sarcoma E Wei, A Mitanoska, Q O’Brien, K Porter, MK Molina, H Ahsan, U Jung, ... Molecular Cancer 23 (1), 222, 2024 | | 2024 |
| Heterogeneity analysis of low-risk HPV infection and high-risk HPV infection, HPV-positive and HPV-negative cancers E Wei lmu, 2023 | | 2023 |
